Reaktion #4276

ord-0bc03ba9e5e2470fbc42b20b354ea151

Reaktionsgleichung

CN1c2ccccc2C(c2ccccc2F)=NCC1CCl
1-methyl-2-chloromethyl-5-(2'-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine
Nc1cccc(C(F)(F)F)c1
m-trifluoromethyl aniline
O=C([O-])[O-].[K+].[K+]
potassium carbonate
[I-].[Na+]
sodium iodide
CN1c2ccccc2C(c2ccccc2F)=NCC1CNc1cccc(C(F)(F)F)c1
1-methyl-2-(3'-trifluoromethylphenyl)aminomethyl-5-(2'-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeAfter solvent-removal
  2. 2
    Sonstigepartitioning
  3. 3
    Sonstigeseparation
  4. 4
    Waschenwashing
  5. 5
    Sonstigedrying
  6. 6
    Einengenconcentrating
  7. 7
    Sonstigethe analytical product was obtained via chromatography on silica gel (ethyl acetate-hexane elution, 3:7 v/v)

Vorschrift

According to the method of Example 5, 1-methyl-2-chloromethyl-5-(2'-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine (200 mg, 0.66 mmole) and m-trifluoromethyl aniline (319 mg, 1.97 mmole) were combined in 2 ml of dry N,N-dimethylformamide, and potassium carbonate (273 mg, 1.97 mmole) and sodium iodide (198 mg, 1.32 mmole) were added to this mixture (which was heated at 65° C. for 18 hours). After solvent-removal, partitioning, separation, washing, drying and concentrating, the analytical product was obtained via chromatography on silica gel (ethyl acetate-hexane elution, 3:7 v/v) and was shown to be 96% pure by HPLC.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US04724237uspto-grants-1988_02